“ANTIBODY-CONJUGATED NANOPARTICLES FOR TARGETED CANCER DRUG DELIVERY”. 2026. Global Conference on Medical and Health Sciences 1 (9): 129-36. https://econferencia.com/index.php/5/article/view/1477.